In this video, Atul Deodhar, MD, provides an overview of results from a phase 3 study that assessed whether the oral JAK inhibitor tofacitinib could be a treatment option for adults with ankylosing spondylitis. He had presented on the topic...
In this video, Atul Deodhar, MD, provides an overview of results from a phase 3 study that assessed whether the oral JAK inhibitor tofacitinib could be a treatment option for adults with ankylosing spondylitis. He had presented on the topic...
In this video, Atul Deodhar, MD,...